US3.3

Merck snags Chinese cancer drug for up to US$3.3 billion

November 14, 2024

[ad_1] MERCK & Co licenced an experimental cancer antibody from a closely held Chinese company in a deal worth US$588 million upfront, plus as much as US$2.7 billion in milestone...

Hyundai Motor India dips in debut after record US$3.3 billion IPO

October 22, 2024

[ad_1] HYUNDAI Motor India shares slipped as much as 2.6 per cent early in their Mumbai debut, a lacklustre start to trading in what has been one of the world’s...

Crop trader Olam to pay US$3.3 million fine for delayed cotton sales reports

September 29, 2024

[ad_1] CROP trader Olam Group will pay a US$3.3 million fine for delayed reporting of cotton sales to the US Department of Agriculture (USDA) and the Commodity Futures Trading Commission...